Skip to Content

News Release

MIM to Present at CIBC World Markets Health Care Conference

October 30, 2002 at 3:18 PM EST

ELMSFORD, N.Y.--Oct. 30, 2002--MIM Corporation (NASDAQ: MIMS; CBOE: OQX; AMEX: OQX), a pharmaceutical healthcare organization, today announced that it will present at the CIBC World Markets Thirteenth Annual Health Care Conference on November 4-6, at The Plaza Hotel in New York City.

MIM Chief Financial Officer James S. Lusk will present on November 4, at 9:00 AM ET.

Investors may access a webcast of the presentation on the MIM Corporation website, www.mimcorporation.com, on the presentations page of the investor information section.

MIM Corporation (www.mimcorporation.com) is a pharmaceutical healthcare organization delivering innovative pharmacy benefit and healthcare solutions that provide results beyond expectations. We excel by harnessing our clinical expertise, sophisticated data management, and therapeutic fulfillment capability, and combine it with our dedicated, responsive team of professionals that understands our partners' needs. The result is cost-effective solutions enhancing the quality of patient life.

This press release may contain statements which constitute forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the intent, belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company. Investors are cautioned that any such forward looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward looking statements as a result of various factors. Important factors that could cause such differences are described in the Company's periodic filings with the Securities and Exchange Commission.


Contact:
     MIM Corporation
     James S. Lusk, 914/460-1648
     jlusk@mimcorporation.com
         or
     The Anne McBride Co.
     Investor Relations:
     Rachel Levine, 212/983-1702
     rlevine@annemcbride.com

Source: MIM Corporation